Mill Creek Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $382K | Sell |
2,060
-1,178
| -36% | -$219K | 0.01% | 184 |
|
|
2025
Q1 | $679K | Buy |
3,238
+112
| +4% | +$23.5K | 0.02% | 137 |
|
|
2024
Q4 | $555K | Sell |
3,126
-141
| -4% | -$25.1K | 0.01% | 156 |
|
|
2024
Q3 | $645K | Sell |
3,267
-470
| -13% | -$92.8K | 0.02% | 145 |
|
|
2024
Q2 | $641K | Buy |
3,737
+316
| +9% | +$54.2K | 0.02% | 151 |
|
|
2024
Q1 | $623K | Sell |
3,421
-497
| -13% | -$90.5K | 0.02% | 143 |
|
|
2023
Q4 | $607K | Buy |
3,918
+34
| +0.9% | +$5.27K | 0.02% | 142 |
|
|
2023
Q3 | $579K | Sell |
3,884
-1,234
| -24% | -$184K | 0.02% | 131 |
|
|
2023
Q2 | $690K | Buy |
5,118
+987
| +24% | +$133K | 0.02% | 129 |
|
|
2023
Q1 | $658K | Sell |
4,131
-168
| -4% | -$26.8K | 0.02% | 131 |
|
|
2022
Q4 | $695K | Buy |
+4,299
| New | +$695K | 0.03% | 121 |
|